Excited to announce the successful completion of our Phase 1b/2a trial for SPT-2101 in Meniere’s disease! Big thanks to our team and collaborators. This is just the beginning as we work to transform treatments for inner ear disorders. https://t.co/7wPFBj9NZc
Very proud of this recognition of our recent developments in the treatment of Meniere's Disease and around our MICS™️ drug delivery platform. We have some exciting milestones coming up later this year. Stay tuned!
We are excited to announce the publication of our manuscript, "Early Experience with a Novel Treatment for Ménière's disease: A Long Acting Dexamethasone Formulation for Precise Delivery to the Round Window Membrane" in Otology & Neurotology. https://t.co/Tr0lpLM2IC
✨️Hoy celebramos el #DiaMundialdelaAudicion, y desde el grupo de Neuropatología de la Audición y Mielinopatias te invitamos a que veas el video divulgativo que hemos preparado para la ocasión ▶️ https://t.co/Sn3cstyc5B
#WorldHearingDay
On 𝐖𝐨𝐫𝐥𝐝 𝐇𝐞𝐚𝐫𝐢𝐧𝐠 𝐃𝐚𝐲, we at Spiral Therapeutics are proud to contribute to the advancement of treatments for hearing loss. Our dedication extends to promoting hearing health awareness. @CSIC@CienciaGob@FIAPAS https://t.co/xLth8l3bhK
Regular Hearing Aid Use Linked to Longer Lifespan: Study Finds 24% Decreased Risk of Early Death. #hearingaids#hearinghealth#longevity https://t.co/z9p4oMR2qh
The new JARO issue is now online featuring a review on somatosenrory #tinnitus, cochlear #synaptopathy in birds, machine learning for the count of auditory neurons in human cochleas, and polygenic risk scores for #hearingloss!
https://t.co/QzRGhAltTt
@thenew111116950 @RinriTx Thanks for your support and interest! We are actively working on our pipeline and our second asset should reach the clinic in early 2025
Spiral sponsored the 2023 Charleston Vestibular Conference, directed by our clinical advisor Dr. Habib Rizk and Danielle Cassels, AuD at @muschollings.
Spiral's Director of R&D, Benson Jung introduced SPT-2101, our treatment for Meniere’s disease.
Spiral sponsored the 2023 Charleston Vestibular Conference, directed by our clinical advisor Dr. Habib Rizk and Danielle Cassels, AuD at @muschollings.
Spiral's Director of R&D, Benson Jung introduced SPT-2101, our treatment for Meniere’s disease.